Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

This study was designed to investigate the impact of blood tumor mutational burden (bTMB) on advanced NSCLC in Southwest China. The relationship between the tTMB estimated by next-generation sequencing (NGS) and clinical outcome was retrospectively analyzed in tissue specimens from 21 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yuhui, Li, Quan, Du, Yaxi, Cai, Jingjing, Chen, Wanlin, Zhao, Guangqiang, Liu, Xing, Li, Hongsheng, Ma, Luyao, Huang, Yunchao, Zhou, Yongchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160368/
https://www.ncbi.nlm.nih.gov/pubmed/34055609
http://dx.doi.org/10.3389/fonc.2021.640761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160368/
https://www.ncbi.nlm.nih.gov/pubmed/34055609
http://dx.doi.org/10.3389/fonc.2021.640761

Ejemplares similares